Intel Nears Foundry Inflection Point
Rick Merritt, SiliconValley Bureau Chief
EETimes (11/22/2013 12:58 PM EST)
SAN JOSE, Calif. — Intel's new chief executive Brian Krzanich is clearly on the hot seat. The world's largest chip maker told analysts yesterday 2014 will be another flat year for the company accustomed to outpacing chip industry growth, yet it is maintaining historically high capex spending, seeing the need for a new 450mm fab on the horizon.
The good news is Intel claims it will have an edge over the rest of the industry in lower cost with its 14nm process that's now ramping. The bad news is it doesn't appear to have any hot smartphone products to make in the process next year, and it's not clear to what extent it will let high volume competitors use its fabs.
|
|
E-mail This Article |
|
Printer-Friendly Page |
|
||||||
Related News
- Keysight EDA and Intel Foundry Collaborate on EMIB-T Silicon Bridge Technology for Next-Generation AI and Data Center Solutions
- IC'Alps joins Intel Foundry Accelerator program as Value Chain Alliance (VCA) and Design Services Alliance (DSA) partner
- Intel Foundry Gathers Customers and Partners, Outlines Priorities
- Arteris Joins Intel Foundry Accelerator Ecosystem Alliance Program to Support Advanced Semiconductor Designs
- SkyeChip Joins Intel Foundry Accelerator IP Alliance
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






